194
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Improvement of dissolution profile of eplerenone with solidified self-emulsifying drug delivery systems (S-SEDDS)

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 305-315 | Received 09 Sep 2022, Accepted 27 Apr 2023, Published online: 10 May 2023

References

  • Sunitha R, Satya Sireesha D, Aparna MVL. Novel self-emulsifying drug delivery system–an approach to enhance bioavailability of poorly water soluble drugs. Int J Res Pharm Chem. 2011;1(4):828–838.
  • Singh B, Bandopadhyay S, Kapil R, et al. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst. 2009;26(5):427–521.
  • Pouton CW, Charman WN. The potential of oily formulations for drug delivery to the gastrointestinal tract: preface. Adv Drug Deliv Rev. 1997;25(1):1–2.
  • Patil SL, Pharm IJ, Sci B, et al. International journal of pharmacy and biological sciences (eISSN: 2230-7605) self emulsifying drug delivery system (SEDDS): a review. Indian J Pharm Biol Sci. 2012;2(2):42–52.
  • Kadu PJ, Kushare SS, Thacker DD, et al. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS). Pharm Dev Technol. 2011;16(1):65–74.
  • Patel D, Sawant K. Self micro-emulsifying drug delivery system: formulation development and biopharmaceutical evaluation of lipophilic drugs. Curr Drug Deliv. 2009;6(4):419–424.
  • Gupta S, Kesarla R, Omri A. Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm. 2013;2013:1–16.
  • Wagh M, Singh PK, Chaudhari CK. DA. Solid self emulsifying drug delivery system: preparation techniques and dosage forms. Int J Biopharm. 2014;5(2):101–108.
  • Cook CS, Zhang L. Atypical dose-route-dependent food effects of eplerenone in the dog: presence of food effects following intravenous dosing and lack of food effects of following oral dosing. J Pharm Sci. 2002;91(3):607–614.
  • Khames A. Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique. Drug Deliv. 2017;24(1):328–338.
  • Ranna R. Bioavailability enhancement of poorly soluble drugs with the approach of self-emulsifying drug delivery systems. [Master Thesis]. Istanbul Turkey (TR): Yeditepe University; 2021.
  • Gurram AK, Deshpande PB, Kar SS, et al. Role of components in the formation of self-microemulsifying drug delivery systems. Indian J Pharm Sci. 2015;77(3):249–257.
  • Patel AR, Vavia PR. Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J Incl Phenom Macrocycl Chem. 2006;56(1-2):247–251.
  • Dixit AR, Rajput SJ, Patel SG. Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech. 2010;11(1):314–321.
  • Yeom DW, Chae BR, Son HY, et al. Enhanced oral bioavailability of valsartan using a polymer-based supersaturable self-microemulsifying drug delivery system. Int J Nanomedicine. 2017;12:3533–3545.
  • Khan F, Islam MS, Roni MA, et al. Systematic development of self-emulsifying drug delivery systems of atorvastatin with improved bioavailability potential. Sci Pharm. 2012;80(4):1027–1043.
  • Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58(3):173–182.
  • Tan A, Rao S, Prestidge CA. Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance. Pharm Res. 2013;30(12):2993–3017.
  • Katteboinaa S, Chandrasekhar PVSR, Balaji S. Approaches for the development of solid self-emulsifying drug delivery systems and dosage forms. Asian J Pharma Sci. 2009;4(4):240–253.
  • Assi RA, Abdulbaqi IM, Ming TS, et al. Liquid and solid self-emulsifying drug delivery systems (sedds) as carriers for the oral delivery of azithromycin: optimization, in vitro characterization and stability assessment. Pharmaceutics. 2020;12:1–29.
  • Hauptstein S, Prüfert F, Bernkop-Schnürch A. Self-nanoemulsifying drug delivery systems as novel approach for pDNA drug delivery. Int J Pharm. 2015;487(1-2):25–31.
  • Chintalapudi R, Murthy TEGK, Lakshmi KR, et al. Formulation, optimization, and evaluation of self-emulsifying drug delivery systems of nevirapine. Int J Pharm Investig. 2015;5(4):205–213.
  • Patil P, Patil V, Paradkar A. Formulation of a self-emulsifying system for oral delivery of simvastatin: in vitro and in vivo evaluation. Acta Pharm. 2007;57(1):111–122.
  • Asif S, Naveed S, Usmanghani K, et al. Validation of RP-HPLC method for estimation of eplerenone in bulk and pharmaceutical formulations. RADS J Pharm Pharm Sci. 2017;5:20–26.
  • Khames A. Formulation and characterization of eplerenone nanoemulsion liquisolids, an oral delivery system with higher release rate and improved bioavailability. Pharmaceutics. 2019;11(1):40.
  • Dixit RP, Nagarsenker MS. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur J Pharm Sci. 2008;35(3):183–192.
  • Almeida SRD, Tippavajhala VK. A rundown through various methods used in the formulation of solid self-emulsifying drug delivery systems (S-SEDDS). AAPS PharmSciTech. 2019;20(8):323.
  • Shazly G, Mohsin K. Dissolution improvement of solid self-emulsifying drug delivery systems of fenofibrate using an inorganic high surface adsorption material. Acta Pharm. 2015;65(1):29–42.
  • Wadhwa J, Nair A, Kumria R. Self-emulsifying therapeutic system: a potential approach for delivery of lipophilic drugs. Braz. J. Pharm. Sci. 2011;47(3):447–465.
  • Azeem A, Rizwan M, Ahmad FJ, et al. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech. 2009;10(1):69–76.
  • Chime SA, Kenechukwu FC, Attama AA. Nanoemulsions-Advances in formulation, characterization and applications in drug delivery. In: Sezer AD, editor. Application of nanotechnology in drug delivery. Rijeka, Croatia: IntechOpen; 2014. p.77–126.
  • Czajkowska-Kośnik A, Szekalska M, Amelian A, et al. Development and evaluation of liquid and solid self-emulsifying drug delivery systems for atorvastatin. Molecules. 2015;20(12):21010–21022.
  • Parmar B, Patel U, Bhimani B, et al. SMEDDS : a dominant dosage form which improve bioavailability. Am J PharmTech Res. 2012;2:54–72.
  • Gupta AK, Mishra DK, Mahajan SC. Preparation and in vitro evaluation of self emulsifying drug delivery system of antihypertensive drug valsartan. Int J Pharm Life Sci. 2011;2:633–639.
  • Snela A, Jadach B, Froelich A, et al. Self-emulsifying drug delivery systems with atorvastatin adsorbed on solid carriers: formulation and in vitro drug release studies. Colloids Surfaces A Physicochem Eng Asp. 2019;577:281–290.
  • Tung NT, Tran CS, Pham TM, et al. Development of solidified self-microemulsifying drug delivery systems containing l-tetrahydropalmatine: design of experiment approach and bioavailability comparison. Int J Pharm. 2018;537(1-2):9–21.
  • Joyce P, Dening TJ, Meola TR, et al. Solidification to improve the biopharmaceutical performance of SEDDS: opportunities and challenges. Adv Drug Deliv Rev. 2019;142:102–117.
  • Yetukuri K, Sudheer P. Approaches to development of solid- self micron emulsifying drug delivery system: formulation techniques and dosage forms : a review. IJPSR. 2012;3(10):3550–3558.
  • Gumaste SG, Pawlak SA, Dalrymple DM, et al. Development of solid SEDDS, IV: effect of adsorbed lipid and surfactant on tableting properties and surface structures of different silicates. Pharm Res. 2013;30(12):3170–3185.
  • Prajapat MD, Patel NJ, Bariya A, et al. Formulation and evaluation of self-emulsifying drug delivery system for nimodipine, a BCS class II drug. J Drug Deliv Sci Technol. 2017;39:59–68.
  • Craig DQM, Barker SA, Banning D, et al. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm. 1995;114(1):103–110.
  • Kommuru TR, Gurley B, Khan MA, et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212(2):233–246.
  • Gershanik T, Benzeno S, Benita S. Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm Res. 1998;15(6):863–869.
  • Oh DH, Kang JH, Kim DW, et al. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm. 2011;420(2):412–418.
  • Guan Q, Zhang G, Sun S, et al. Enhanced oral bioavailability of pueraria flavones by a novel solid self-microemulsifying drug delivery system (SMEDDS) dropping pills. Biol Pharm Bull. 2016;39(5):762–769.
  • Gardner CR, Walsh CT, Almarsson Ö. Drugs as materials: valuing physical form in drug discovery. Nat Rev Drug Discov. 2004;3(11):926–934.
  • Skotnicki M, Gaweł A, Cebe P, et al. Thermal behavior and phase identification of valsartan by standard and temperature-modulated differential scanning calorimetry. Drug Dev Ind Pharm. 2013;39(10):1508–1514.
  • Nekkanti V, Karatgi P, Prabhu R, et al. Solid self-microemulsifying formulation for candesartan cilexetil. AAPS PharmSciTech. 2010;11(1):9–17.
  • Kazi M, Al-Qarni H, Alanazi FK. Development of oral solid self-emulsifying lipid formulations of risperidone with improved in vitro dissolution and digestion. Eur J Pharm Biopharm. 2017;114:239–249.
  • Dangre PV, Tattu AD, Borikar SP, et al. Development and statistical optimization of alginate-Neusilin US2 micro-composite beads to elicit gastric stability and sustained action of hesperidin. Int J Biol Macromol. 2021;171:514–526.
  • You J, Li QP, Han X, et al. A novel formulation design about water-insoluble oily drug: preparation of zedoary turmeric oil microspheres with self-emulsifying ability and evaluation in rabbits. Int J Pharm. 2005;288(2):315–323.
  • Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37–42.
  • Üner B, Özdemir S, Taş Ç, et al. Development of lipid nanoparticles for transdermal loteprednol etabonate delivery. J Microencapsul. 2022;39:1–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.